Ming-yue Bao

Key Laboratory Of Medicinal Resources And Natural Pharmaceutical Chemistry
Xi'an, 710119, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Oral Milk-Derived Extracellular Vesicles: A Promising Drug Delivery System for Neuroinflammatory Diseases.

Oral Milk-Derived Extracellular Vesicles: A Promising Drug Delivery System for Neuroinflammatory Diseases.

Journal: ACS biomaterials science & engineering

Published: May 29, 2026

Spironolactone Targets Retinoid X Receptor γ to Promote Myelin Sheath Regeneration.

Spironolactone Targets Retinoid X Receptor γ to Promote Myelin Sheath Regeneration.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: October 08, 2025

Advances in understanding lipid metabolism in oligodendrocyte development and neurodegenerative diseases.

Advances in understanding lipid metabolism in oligodendrocyte development and neurodegenerative diseases.

Journal: Clinical science (London, England : 1979)

Published: August 11, 2025

Oligodendrocyte-encoded lactate dehydrogenase A couples glycolysis to remyelination via protein lactylation.

Oligodendrocyte-encoded lactate dehydrogenase A couples glycolysis to remyelination via protein lactylation.

Journal: Neuron

Published: June 05, 2025

Nuclear receptor PPARγ targets GPNMB to promote oligodendrocyte development and remyelination.

Nuclear receptor PPARγ targets GPNMB to promote oligodendrocyte development and remyelination.

Journal: Brain : a journal of neurology

Published: March 23, 2024

Dietary ellagic acid therapy for CNS autoimmunity: Targeting on Alloprevotella rava and propionate metabolism.

Dietary ellagic acid therapy for CNS autoimmunity: Targeting on Alloprevotella rava and propionate metabolism.

Journal: Microbiome

Published: July 23, 2023

Targeting of KOR by famotidine promotes OPC maturation differentiation and CNS remyelination via STAT3 signaling pathway.

Targeting of KOR by famotidine promotes OPC maturation differentiation and CNS remyelination via STAT3 signaling pathway.

Journal: International journal of biological macromolecules

Published: June 13, 2023

Peroxisom proliferator-activated receptor-γ coactivator-1α in neurodegenerative disorders: A promising therapeutic target.

Peroxisom proliferator-activated receptor-γ coactivator-1α in neurodegenerative disorders: A promising therapeutic target.

Journal: Biochemical pharmacology

Published: June 11, 2023

Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α in the Spotlight with Multiple Sclerosis.

Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α in the Spotlight with Multiple Sclerosis.

Journal: Neuroscience bulletin

Published: May 12, 2023

Corrigendum to "2', 4'-Dihydroxy-2,3-dimethoxychalcone: A pharmacological inverse agonist of RORγt ameliorating Th17-driven inflammatory diseases by regulating Th17/Treg". [Int. Immunopharmacol. 108 (2022) 108769].

Corrigendum to "2', 4'-Dihydroxy-2,3-dimethoxychalcone: A pharmacological inverse agonist of RORγt ameliorating Th17-driven inflammatory diseases by regulating Th17/Treg". [Int. Immunopharmacol. 108 (2022) 108769].

Journal: International immunopharmacology

Published: September 26, 2022

2', 4'-Dihydroxy-2,3-dimethoxychalcone: A pharmacological inverse agonist of RORγt ameliorating Th17-driven inflammatory diseases by regulating Th17/Treg.

2', 4'-Dihydroxy-2,3-dimethoxychalcone: A pharmacological inverse agonist of RORγt ameliorating Th17-driven inflammatory diseases by regulating Th17/Treg.

Journal: International immunopharmacology

Published: February 09, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026